Iridex Corporation

IPO

Iridex Corporation is a healthcare company in Mountain View, United States, founded in 1989. It has raised $10.0M across 2 rounds, most recently a $4.0M Convertible Note in March 2025.

Advancing laser therapies for ophthalmology

Employees
51–200
Founded
1989
Business Model
B2B
Website
iridex.com
Total Funding
$10.0M
Last Round
$4.0M Convertible NoteMar 2025
Rounds
2
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds for this company. The full record is or through the API.

About

IRIDEX Corporation is a publicly traded (Nasdaq: IRIX) medical device company headquartered in Mountain View, California. Founded in 1989, the company is a worldwide leader in developing, manufacturing, and marketing innovative laser-based medical systems, delivery devices, and single-use consumables for the treatment of retinal diseases and glaucoma. Its product lines include the IQ 532, IQ 810, and IQ 577 laser systems powered by proprietary MicroPulse technology, which enables repeatable, tissue-sparing therapies. IRIDEX products are sold through a global network of distributors and direct sales teams.

Summary

It lists 51–200 employees. It has raised $10.0M in total across 2 rounds, most recently a $4.0M Convertible Note round in Mar 2025.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
ConvertibleConvertible NoteMar 2025
$4.0M

Sign up to see all 2 events

Funding: Convertible Note through Series B. Amounts, valuations, and investors where available.

Similar Companies

Neko Health

Neko Health delivers preventive health scans that combine skin, heart, blood, and body measuremen...

Stockholm, Sweden201–500Artificial Intelligence, Digital Health
Series CTotal funding$1.1BJul 2026
MultiPlanIPO

Healthcare cost management company providing data analytics and network-based payment solutions t...

New York, United States1001–5000Healthcare
Private EquityTotal funding$7.4BMar 2014
The Bountiful CompanyAcquired

American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...

Ronkonkoma, United States1001–5000Healthcare, Retail
Private EquityTotal funding$7.0BJul 2017
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
OneOncologyAcquired

OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...

Nashville, United States1001–5000Healthcare, Data & Analytics
Extension RoundTotal funding$5.1BDec 2025
Canopy Growth Corporation Common SharesIPO

World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...

Smiths Falls, Canada1001–5000Healthcare
Corporate RoundTotal funding$4.5BJan 2024

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Iridex Corporation on Indexed.vc
<a href="https://indexed.vc/companies/iridex-corporation"><img src="https://indexed.vc/api/badge/company/iridex-corporation" alt="Iridex Corporation on Indexed.vc" width="260" height="76" /></a>